Relationship between myocardial bridging and coronary arteriosclerosis

Cell Biochem Biophys. 2013 Apr;65(3):485-9. doi: 10.1007/s12013-012-9438-y.

Abstract

The objective of the study was to explore the prevalence and characteristics of myocardial bridging in patients who underwent coronary angiography and to also evaluate the correlation between bridged coronary segments and atherosclerosis. For this purpose, clinical materials of 1,500 patients who had received coronary angiography were retrospectively analyzed. The location and length of the myocardial bridge were recorded as well as the extent and location of coronary artery stenosis was described. Segments proximal and distal to the bridging were evaluated for coronary arteriosclerosis as were the remaining coronary segments. We found that myocardial bridging was present in 179 (11.9 %) patients. Bridges were frequently (84.9 %) localized in the mid-distal segment of the left anterior descending (LAD) artery. Myocardial bridging was not considered a significant risk factor for coronary atherosclerosis (odds ratio 0.58) compared with traditional cardiovascular risk factors. The incidence of coronary arteriosclerosis in the distal segments was significantly less affected than the proximal segments (P < 0.01). It was, therefore, concluded that myocardial bridging frequently localized in the mid-distal segment of the LAD artery. The presence of myocardial bridging promotes proximal atherosclerosis but it is not an additional risk factor for coronary atherosclerosis.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Coronary Angiography
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / etiology
  • Coronary Stenosis / diagnostic imaging
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Bridging / diagnostic imaging*
  • Myocardial Bridging / drug therapy
  • Myocardial Bridging / epidemiology
  • Odds Ratio
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index

Substances

  • Adrenergic beta-Antagonists